Fund profile
Fund manager
Total assets
$47.46 mm
Liabilities
$2.34 mm
Net assets
$45.11 mm
Number of holdings
128.00
128 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
Invesco Government & Agency Portfolio | 2.23 mm | 2.23 mm shares | 4.93 | Short-term investment vehicle | N/A | USA |
CYTK Cytokinetics Inc | 1.23 mm | 14.76 k shares | 2.73 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 775.13 k | 2.45 k shares | 1.72 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 750.97 k | 23.99 k shares | 1.66 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 651.50 k | 15.22 k shares | 1.44 | Common equity | Long | Virgin Islands (British) |
FOLD Amicus Therapeutics Inc | 632.58 k | 44.58 k shares | 1.40 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 627.42 k | 6.80 k shares | 1.39 | Common equity | Long | USA |
MRNA Moderna Inc | 626.44 k | 6.30 k shares | 1.39 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 626.20 k | 20.46 k shares | 1.39 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 624.69 k | 15.47 k shares | 1.38 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 594.79 k | 12.44 k shares | 1.32 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 591.34 k | 25.33 k shares | 1.31 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 586.91 k | 20.46 k shares | 1.30 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 584.70 k | 1.44 k shares | 1.30 | Common equity | Long | USA |
KRYS Krystal Biotech Inc | 584.20 k | 4.71 k shares | 1.29 | Common equity | Long | USA |
INCY Incyte Corp. | 577.67 k | 9.20 k shares | 1.28 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 575.86 k | 7.78 k shares | 1.28 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 574.89 k | 51.19 k shares | 1.27 | Common equity | Long | Bermuda |
IOVA Iovance Biotherapeutics Inc | 568.48 k | 69.92 k shares | 1.26 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 566.57 k | 2.96 k shares | 1.26 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 565.38 k | 4.29 k shares | 1.25 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 559.01 k | 2.42 k shares | 1.24 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 557.96 k | 56.59 k shares | 1.24 | Common equity | Long | USA |
INSM Insmed Inc | 557.76 k | 18.00 k shares | 1.24 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 557.66 k | 8.88 k shares | 1.24 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 557.56 k | 5.78 k shares | 1.24 | Common equity | Long | USA |
EXEL Exelixis Inc | 548.72 k | 22.87 k shares | 1.22 | Common equity | Long | USA |
TGTX TG Therapeutics Inc | 546.75 k | 32.01 k shares | 1.21 | Common equity | Long | USA |
BIIB Biogen Inc | 544.19 k | 2.10 k shares | 1.21 | Common equity | Long | USA |
NTRA Natera Inc | 542.09 k | 8.65 k shares | 1.20 | Common equity | Long | USA |
IMVT Immunovant Inc | 540.95 k | 12.84 k shares | 1.20 | Common equity | Long | USA |
ALKS Alkermes plc | 539.40 k | 19.45 k shares | 1.20 | Common equity | Long | Ireland |
AMGN AMGEN Inc. | 538.60 k | 1.87 k shares | 1.19 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 528.88 k | 17.35 k shares | 1.17 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 526.10 k | 599.00 shares | 1.17 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 524.99 k | 19.05 k shares | 1.16 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 524.11 k | 7.12 k shares | 1.16 | Common equity | Long | USA |
MRTX Mirati Therapeutics Inc | 523.35 k | 8.91 k shares | 1.16 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 522.44 k | 10.33 k shares | 1.16 | Common equity | Long | USA |
ABBV Abbvie Inc | 522.40 k | 3.37 k shares | 1.16 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 522.11 k | 5.42 k shares | 1.16 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 518.30 k | 19.04 k shares | 1.15 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 515.87 k | 6.37 k shares | 1.14 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 510.81 k | 17.23 k shares | 1.13 | Common equity | Long | USA |
HSBC SECURITIES USA INC | 494.00 k | 494.00 k principal | 1.10 | Repurchase agreement | Long | USA |
CRSP CRISPR Therapeutics AG | 488.09 k | 7.80 k shares | 1.08 | Common equity | Long | Switzerland |
SNDX Syndax Pharmaceuticals Inc | 487.87 k | 22.58 k shares | 1.08 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 487.16 k | 13.69 k shares | 1.08 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 479.66 k | 8.01 k shares | 1.06 | Common equity | Long | USA |
ARDX Ardelyx Inc | 478.00 k | 77.10 k shares | 1.06 | Common equity | Long | USA |
TWST Twist Bioscience Corp | 474.35 k | 12.87 k shares | 1.05 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 465.55 k | 12.60 k shares | 1.03 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 458.03 k | 2.08 k shares | 1.02 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 449.98 k | 39.33 k shares | 1.00 | Common equity | Long | USA |
NVAX Novavax, Inc. | 433.64 k | 90.34 k shares | 0.96 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 431.10 k | 23.17 k shares | 0.96 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 423.38 k | 30.29 k shares | 0.94 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 422.45 k | 11.63 k shares | 0.94 | Common equity | Long | Ireland |
SOCIETE GENERALE | 397.00 k | 397.00 k principal | 0.88 | Repurchase agreement | Long | USA |
DNLI Denali Therapeutics Inc | 387.27 k | 18.05 k shares | 0.86 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 385.62 k | 10.84 k shares | 0.85 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 372.77 k | 17.20 k shares | 0.83 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 350.74 k | 11.70 k shares | 0.78 | Common equity | Long | USA |
ACLX Arcellx Inc | 348.21 k | 6.27 k shares | 0.77 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 336.23 k | 7.93 k shares | 0.75 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals Inc | 331.81 k | 19.74 k shares | 0.74 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 329.06 k | 8.30 k shares | 0.73 | Common equity | Long | USA |
MORF Morphic Holding Inc | 328.16 k | 11.36 k shares | 0.73 | Common equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 320.82 k | 53.56 k shares | 0.71 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals Inc. | 314.20 k | 6.84 k shares | 0.70 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 305.80 k | 20.19 k shares | 0.68 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 295.72 k | 8.10 k shares | 0.66 | Common equity | Long | USA |
ETNB 89bio Inc | 284.03 k | 25.43 k shares | 0.63 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 269.16 k | 14.09 k shares | 0.60 | Common equity | Long | USA |
CABA Cabaletta Bio Inc | 266.25 k | 11.73 k shares | 0.59 | Common equity | Long | USA |
VRDN Viridian Therapeutics Inc | 247.20 k | 11.35 k shares | 0.55 | Common equity | Long | USA |
VCYT Veracyte Inc | 245.88 k | 8.94 k shares | 0.55 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 238.28 k | 17.09 k shares | 0.53 | Common equity | Long | USA |
VIR Vir Biotechnology Inc | 224.96 k | 22.36 k shares | 0.50 | Common equity | Long | USA |
INBX Inhibrx Inc | 219.87 k | 5.79 k shares | 0.49 | Common equity | Long | USA |
REPL Replimune Group Inc | 218.69 k | 25.94 k shares | 0.48 | Common equity | Long | USA |
TVTX Travere Therapeutics Inc | 216.25 k | 24.05 k shares | 0.48 | Common equity | Long | USA |
PTGX Protagonist Therapeutics Inc | 215.86 k | 9.41 k shares | 0.48 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 215.70 k | 7.31 k shares | 0.48 | Common equity | Long | USA |
VCEL Vericel Corp | 211.20 k | 5.93 k shares | 0.47 | Common equity | Long | USA |
IBRX ImmunityBio Inc | 208.15 k | 41.47 k shares | 0.46 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 202.73 k | 18.41 k shares | 0.45 | Common equity | Long | USA |
EDIT Editas Medicine Inc | 202.11 k | 19.95 k shares | 0.45 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 199.99 k | 6.34 k shares | 0.44 | Common equity | Long | USA |
GERN Geron Corp. | 197.39 k | 93.55 k shares | 0.44 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 193.42 k | 13.25 k shares | 0.43 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 191.50 k | 8.60 k shares | 0.42 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 183.78 k | 9.60 k shares | 0.41 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 171.50 k | 6.74 k shares | 0.38 | Common equity | Long | USA |
MNKD Mannkind Corp | 166.70 k | 45.80 k shares | 0.37 | Common equity | Long | USA |
CREDIT AGRICOLE CIB NY | 159.00 k | 159.00 k principal | 0.35 | Repurchase agreement | Long | USA |
NATWEST MARKETS PLC | 159.00 k | 159.00 k principal | 0.35 | Repurchase agreement | Long | USA |
ROYAL BANK OF CANADA | 159.00 k | 159.00 k principal | 0.35 | Repurchase agreement | Long | USA |
VERA Vera Therapeutics Inc - Ordinary Shares | 147.22 k | 9.57 k shares | 0.33 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 145.48 k | 3.66 k shares | 0.32 | Common equity | Long | USA |
XNCR Xencor Inc | 142.58 k | 6.72 k shares | 0.32 | Common equity | Long | USA |
QURE uniQure N.V. | 139.93 k | 20.67 k shares | 0.31 | Common equity | Long | Netherlands |
CDMO Avid Bioservices Inc | 138.87 k | 21.36 k shares | 0.31 | Common equity | Long | USA |
ADMA Adma Biologics Inc | 137.90 k | 30.51 k shares | 0.31 | Common equity | Long | USA |
IRON Disc Medicine Inc | 129.04 k | 2.23 k shares | 0.29 | Common equity | Long | USA |
CDNA Caredx Inc | 128.06 k | 10.67 k shares | 0.28 | Common equity | Long | USA |
RAPT RAPT Therapeutics Inc | 127.53 k | 5.13 k shares | 0.28 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 126.20 k | 7.82 k shares | 0.28 | Common equity | Long | USA |
CRBU Caribou Biosciences Inc | 122.63 k | 21.40 k shares | 0.27 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 122.27 k | 9.19 k shares | 0.27 | Common equity | Long | USA |
KURA Kura Oncology Inc | 121.94 k | 8.48 k shares | 0.27 | Common equity | Long | USA |
RGNX Regenxbio Inc | 121.27 k | 6.76 k shares | 0.27 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corporation | 121.08 k | 13.01 k shares | 0.27 | Common equity | Long | USA |
SLNO Soleno Therapeutics Inc | 117.05 k | 2.91 k shares | 0.26 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 113.48 k | 6.04 k shares | 0.25 | Common equity | Long | USA |
BLUE Bluebird bio Inc | 100.90 k | 73.12 k shares | 0.22 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 99.53 k | 11.00 k shares | 0.22 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 99.09 k | 24.29 k shares | 0.22 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 97.05 k | 4.79 k shares | 0.22 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 95.13 k | 16.18 k shares | 0.21 | Common equity | Long | USA |
KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares | 94.24 k | 5.37 k shares | 0.21 | Common equity | Long | Bermuda |
MDXG Mimedx Group Inc | 89.30 k | 10.18 k shares | 0.20 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 85.62 k | 4.49 k shares | 0.19 | Common equity | Long | USA |
ALEC Alector Inc | 85.39 k | 10.70 k shares | 0.19 | Common equity | Long | USA |
BMEA Biomea Fusion Inc | 82.75 k | 5.70 k shares | 0.18 | Common equity | Long | USA |
MGNX Macrogenics Inc | 51.07 k | 5.31 k shares | 0.11 | Common equity | Long | USA |
UMB FINANCIAL CORP | 50.00 k | 50.00 k principal | 0.11 | Repurchase agreement | Long | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. BIOTECHNOLOGY INDEX
GOLDMAN SACHS GROUP, INC
|
-4.32 k | 142.00 other units | -0.01 | Equity derivative | N/A | USA |